Lipocine Inc expected to post a loss of 64 cents a share - Earnings Preview

Lipocine

04/08/2023 19:37

* Lipocine Inc  LPCN.OQ   LPCN.O  is expected to show a fall
in
quarterly revenue when it reports  results on August 7
(estimated). 
    * The Salt Lake City Utah-based  company is expected to
report  a
43.2% decrease in revenue to $284 thousand from $500 thousand a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Lipocine Inc is for
a
loss of 64 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lipocine
Inc is
$36​, above​ its last closing price of $4.91. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.51       -0.42      -0.68     Missed  -60
 Dec. 31 2023  -0.41       -0.51      -0.51     Met     0
 Sep. 30 2022  -0.68       -0.57      -0.51     Beat    10​
 Jun. 30 2022  -0.68       -0.68      -0.51     Beat    25
 ​​Mar.        0.00        -0.34      -0.68     Missed  -100
 31 2022                                                
 Dec. 31 2021  1.19        -0.17      2.55      Beat    1,600​
 Sep. 30 2021  -0.68       -0.72      -0.51     Beat    29.4
 Jun. 30 2021  -0.85       -0.85      -0.51     Beat    40
 This summary was machine generated August 4 at 18:36 GMT.  All
figures in US dollars  unless otherwise stated